ENLT · Enlight Renewable Energy Ltd.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.

Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.

Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 304.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.811 as of the date immediately preceding the date of the transaction.

Includes (i) 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 21, 2027, and 3,257 vesting on April 21, 2028; and (ii) 11,198 restricted share units granted on October 1, 2025, with 2,799 vesting on each of October 1, 2026 and October 1, 2028, and 2,800 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 300.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.834 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.

Represents a transaction price of NIS 294.05, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 294.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 295.01, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.

Represents a transaction price of NIS 291.05, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 290.35, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 295.01, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 296.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 291.41, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 290.35, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 297.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 292.40, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.

Represents a transaction price of NIS 290.86, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 296.61, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 290.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 1,704 restricted share units granted on April 17, 2024, each of which will vest on April 17, 2027. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 296.61, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 283.90, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on April 24, 2023, with 52,500 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027.

Represents a transaction price of NIS 283.90, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents a transaction price of NIS 283.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.

Includes (i) 12,627 restricted share units granted on April 24, 2024, with 6,313 vesting on April 24, 2027 and 6,314 vesting on April 21, 2028; and (ii) 9,868 restricted share units granted on October 1, 2025, with 2,467 vesting on each of October 1, 2026, October 1, 2027, October 1,2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Represents a transaction price of NIS 270.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.

Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025.

Represents a price of NIS 272.34, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction.

The reporting person is a general partner of Givon Investments Partnership (GAAS), the partnership that owns the reported securities. The partnership is controlled by the Weil family of which the reporting person is a part. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.